Current Bladder Cancer Treatments May Adversely Affect Patients’ Psychosocial Well-Being
A study that was recently published in the “International Journal of Urological Nursing” found that intravesical therapy affected the physical, emotional and social well-being of patients who suffered from non-muscle invasive bladder cancer. The participants of the study underwent intravesical therapy together with either mitomycine (“MMC”) or Bacillus Calmette-Guerin (“BCG”) treatments. The objective of the authors of the study was to evaluate the psychosocial issues these study subjects experienced during therapy and what effects those challenges triggered. In their report, the authors stated that the patients struggled to cope with treatment side effects, adding that this was in addition to…
